Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

Clinical trial NCT04585477 · SUSPENDED

Trial details

NCT number: NCT04585477
Sponsor: Stanford University
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Non-small Cell Lung Cancer Stage I Non-small Cell Lung Cancer Stage II Non-small Cell Lung Cancer Stage III

Start date: 2021-04-08
Primary completion: 2026-12-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.